Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients

Characterization of cell-free circulating DNA in plasma in patients with prostate cancer

(2012) Pâmela Oliveira Delgado et al.   TUMOR BIOLOGY

Rising Incidence of Acute Prostatitis Following Prostate Biopsy: Fluoroquinolone Resistance and Exposure Is a Significant Risk Factor

(2011) Ashraf A. Mosharafa et al.   UROLOGY

Management of Rising Prostate-specific Antigen After a Negative Biopsy

(2011) David A. Levy et al.   Current Urology Reports

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease

(2010) Axel Heidenreich et al.   EUROPEAN UROLOGY

Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer

(2009) H. Schwarzenbach et al.   CLINICAL CANCER RESEARCH

A systematic review of the diagnostic accuracy of prostate specific antigen

(2009) Philip Harvey et al.   BMC Urology

Diagnostic Role of Circulating Free Plasma DNA Detection in Patients With Localized Prostate Cancer

(2008) Annalisa Altimari et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity

(2008) Jörg Ellinger et al.   CANCER LETTERS

Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer

(2008) Jörg Ellinger et al.   JOURNAL OF UROLOGY

Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators

(2007) Jörg Ellinger et al.   INTERNATIONAL JOURNAL OF CANCER